RICHMOND TIMOTHY J. 4
4 · AbbVie Inc. · Filed Mar 5, 2024
Insider Transaction Report
Form 4
AbbVie Inc.ABBV
RICHMOND TIMOTHY J.
SVP, Human Resources
Transactions
- Exercise/Conversion
Common stock, $0.01 par value
2024-03-01$61.36/sh+45,700$2,804,152→ 89,517 total - Sale
Common stock, $0.01 par value
2024-03-01$176.40/sh−15,412$2,718,677→ 74,105 total - Sale
Common stock, $0.01 par value
2024-03-01$177.71/sh−30,288$5,382,480→ 43,817 total - Sale
Common stock, $0.01 par value
2024-03-01$176.35/sh−9,853$1,737,577→ 33,964 total - Sale
Common stock, $0.01 par value
2024-03-01$177.71/sh−20,127$3,576,769→ 13,837 total - Exercise/Conversion
Option (Right to buy)
2024-03-01$61.36/sh−45,700$2,804,152→ 0 totalExercise: $61.36From: 2018-02-16Exp: 2027-02-15→ Common Stock (45,700 underlying)
Footnotes (6)
- [F1]This sale was executed pursuant to a Rule 10b5-1 plan that was entered into by the Reporting Person on November 13, 2023.
- [F2]The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $175.76 to $176.72, inclusive. The reporting person undertakes to provide AbbVie Inc., any security holder of AbbVie Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F3]he price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $176.77 to $177.36, inclusive. The reporting person undertakes to provide AbbVie Inc., any security holder of AbbVie Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F4]The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $175.76 to $176.69, inclusive. The reporting person undertakes to provide AbbVie Inc., any security holder of AbbVie Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F5]The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $176.72 to $177.36, inclusive. The reporting person undertakes to provide AbbVie Inc., any security holder of AbbVie Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F6]Employee stock option granted pursuant to the AbbVie Amended and Restated 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3.